Skip to content
Efmarodocokin alfa
Efmarodocokin alfa is a protein pharmaceutical. It is currently being investigated in clinical studies. It is known to target interleukin-22 receptor subunit alpha-1.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
1 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Graft vs host diseaseD006086D89.811————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameEFMARODOCOKIN ALFA
INNefmarodocokin alfa
Description
Efmarodocokin alfa is a protein pharmaceutical. It is currently being investigated in clinical studies. It is known to target interleukin-22 receptor subunit alpha-1.
Classification
Protein
Drug classFc fusion protein; interleukins
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL4650250
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDNYZ11835VX (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
IL22RA1
IL22RA1
Organism
Homo sapiens
Gene name
IL22RA1
Gene synonyms
IL22R
NCBI Gene ID
58985
Protein name
interleukin-22 receptor subunit alpha-1
Protein synonyms
CRF2-9, Cytokine receptor class-II member 9, Cytokine receptor family 2 member 9, IL-22 receptor subunit alpha-1, IL-22R-alpha-1, IL-22RA1, interleukin 22 receptor, alpha 1, ZcytoR11
Uniprot ID
Q9HB22
Mouse ortholog
Il22ra1 (230828)
interleukin-22 receptor subunit alpha-1 (Q80XZ4)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 5 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details